News Release

Black youth in racist communities fare worse in mental health treatment

A study finds that community-level racism makes it harder for Black youth to benefit from talk therapy

Peer-Reviewed Publication


Washington, DC, June 2, 2022 A study in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), published by Elsevier, reports that Black youth living in communities with high (vs. low) anti-Black racism are less likely to benefit from psychotherapy ("talk therapy;" such as cognitive behavioral therapy).

Racism is a system that labels and ranks racial groups, deeming specific groups as inferior and affording them fewer opportunities and resources. Racism exists across different levels: internally (e.g., low self-esteem due to internalizing racial stereotypes), interpersonally (e.g., being called a racist slur), and structurally (i.e., attitudes and laws/policies that hinder the well-being of people of Color, such as redlining policies). Previous studies find that anti-Black racism across all three levels is related to worse mental health for Black people, though few have examined whether racism affects intervention efficacy (i.e., how beneficial an intervention, such as psychotherapy or medication, is).

This meta-analytic study – led by Dr. Maggi Price, an Assistant Professor at the Boston College School of Social Work – is the first to assess whether structural racism is associated with mental health treatment efficacy. Specifically, the research team used publicly available data on anti-Black racist attitudes to create a measure of state-level structural racism and analyzed randomized controlled trial data from youth psychotherapy studies of mostly Black youth (36 RCTs representing N=2,182 youth).  

Dr. Price and her team found that psychotherapies in states with higher (vs. lower) levels of anti-Black racism were less effective.

While summarizing the study's main finding, Dr. Price said, "The extent to which racism or other prejudicial attitudes are endorsed in a given community – such as a neighborhood or a state – varies across the country. Our study found that the level of racism in one's community affects how well one does in mental health treatment."  

Dr. Price and her colleagues conducted a similar study on structural sexism and found that girls living in places with more (vs. less) sexism also fared worse in treatment. When asked about these studies' implications for mental health treatment providers, Dr. Price said that since "identity and stigma are central to an individual's well-being—and seemingly help to account for how well one responds to mental health treatment—practitioners should address stigma in treatment."

“Providers should also incorporate advocacy into their practice by recognizing and making efforts to reduce sexism and racism in their patients' environments. Some examples might include advocating for  changes in school policies to eliminate racist disciplinary practices or to integrate implicit bias training to help teachers to be more aware of their biases."  

Dr. Price concluded with a call to improve training and education for providers: “Many training programs don't prepare providers to adequately address stigma and identity with patients. We need to enhance training in culturally responsive care, including how to address racism, sexism, and other stigmas in treatment. Doing so is essential and will help us better serve our patients.”


Notes for editors
The article is "Meta-analysis: Are Psychotherapies Less Effective for Black Youth in Communities With Higher Levels of Anti-Black Racism?” by Maggi A. Price, PhD, John R. Weisz, PhD, Sarah McKetta, MSc, Nathan L. Hollinsaid, BS, Micah R. Lattanner, PhD, Allecia E. Reid, PhD, Mark L. Hatzenbuehler, PhD ( It currently appears on the JAACAP Articles In Press page and will appear in the Journal of the American Academy of Child and Adolescent Psychiatry, volume 61, issue 6 (June 2022), published by Elsevier.

Copies of this paper are available to credentialed journalists upon request; please contact the JAACAP Editorial Office at or +1 202 587 9674. Journalists wishing to interview the authors may contact Maggi Price, PhD, e-mail at

Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP) is the official publication of the American Academy of Child and Adolescent Psychiatry. JAACAP is the leading journal focusing exclusively on today's psychiatric research and treatment of the child and adolescent. Published twelve times per year, each issue is committed to its mission of advancing the science of pediatric mental health and promoting the care of youth and their families.

The Journal's purpose is to advance research, clinical practice, and theory in child and adolescent psychiatry. It is interested in manuscripts from diverse viewpoints, including genetic, epidemiological, neurobiological, cognitive, behavioral, psychodynamic, social, cultural, and economic. Studies of diagnostic reliability and validity, psychotherapeutic and psychopharmacological treatment efficacy, and mental health services effectiveness are encouraged. The Journal also seeks to promote the well-being of children and families by publishing scholarly papers on such subjects as health policy, legislation, advocacy, culture and society, and service provision as they pertain to the mental health of children and families.

About Elsevier
As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems.

In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders.

Elsevier employs 8,700 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on our over 2,700 digitized journals, including The Lancet and Cell; our over 43,000 eBook titles; and our iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.

Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.